Changes in Practitioners' Attitudes toward the Recommendations for Clinical Questions of the Japanese Guideline for Management of Hyperuricemia and Gout, Third Edition between 2018 and 2020 in the Questionnaire's Surveys: Involving Their Attitude tow
The third JGMHG plays an important role in popularizing recommendations for serum uric acid levels in patients with tophi and the long-term use of colchicine for prophylaxis of gout flares when initiating ULA, although it did not influence the distribution of responses regarding clinicians' attitudes toward its support.
Authors
- Toshihiro Hamada (ORCID: https://orcid.org/0000-0003-1935-9315)
- Yasuto Sato (ORCID: https://orcid.org/0000-0003-4767-331X)
- Naoyuki Otani (ORCID: https://orcid.org/0000-0002-0127-2118)
- Tsuneo Konta (ORCID: https://orcid.org/0000-0001-7681-6469)
- Masanari Kuwabara (ORCID: https://orcid.org/0000-0002-6601-4347)
- Satoshi Miyazaki (ORCID: https://orcid.org/0000-0003-3309-1618)
- Ichiro Hisatome (ORCID: https://orcid.org/0009-0001-8092-6983)
- Takeo Nakayama (ORCID: https://orcid.org/0000-0002-7918-6252)
- Haruaki Ninomiya (ORCID: https://orcid.org/0000-0001-5412-1180)
Institutions
- Yamagata University (JP)
- Jichi Medical University (JP)
- Kyoto University (JP)
- Tonan Hospital (JP)
- National Institute of Technology, Yonago College (JP)
- National Hospital Organization (JP)
- Miyoshi Kasei (Japan) (JP)
- Tottori University (JP)
- Dokkyo Medical University (JP)
Publication Details
- Journal
- JMA Journal
- Published
- 2025-01-01
- DOI
- https://doi.org/10.31662/jmaj.2024-0399
- Primary Topic
- Gout, Hyperuricemia, Uric Acid
- Type
- article
- Field-Weighted Citation Impact
- 0.00